Revvity, Inc. (RVTY) is a publicly traded Healthcare sector company. As of July 15, 2026, RVTY trades at $111.94 with a market cap of $12.40B and a P/E ratio of 53.80. RVTY moved +0.66% today. Year to date, RVTY is +14.95%; over the trailing twelve months it is +12.94%. Its 52-week range spans $81.22 to $128.29. Analyst consensus is buy with an average price target of $109.00. Rallies surfaces RVTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RVTY, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $111.94 |
| Market Cap | $12.40B |
| P/E Ratio | 53.80 |
| EPS | $2.07 |
| Dividend Yield | 0.07% |
| 52-Week High | $128.29 |
| 52-Week Low | $81.22 |
| Volume | 566 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.86B |
| Net Income | $241.20M |
| Gross Margin | 0.00% |
11 analysts cover RVTY: 0 strong buy, 3 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $109.00.